In the last trading session, 1.37 million shares of the Surgery Partners Inc (NASDAQ:SGRY) were traded, and its beta was 2.58. Most recently the company’s share price was $21.89, and it changed around $0.43 or 2.00% from the last close, which brings the market valuation of the company to $2.84B. SGRY currently trades at a discount to its 52-week high of $36.92, offering almost -68.66% off that amount. The share price’s 52-week low was $21.10, which indicates that the current value has risen by an impressive 3.61% since then. We note from Surgery Partners Inc’s average daily trading volume that its 10-day average is 1.22 million shares, with the 3-month average coming to 933.74K.

Surgery Partners Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.55. If we narrow it down even further, the data shows that 0 out of 12 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 3 recommended SGRY as a Hold, whereas 7 deemed it a Buy, and 0 rated it as Underweight. Surgery Partners Inc is expected to report earnings per share of 0.37 for the current quarter.

Surgery Partners Inc (NASDAQ:SGRY) trade information

Instantly SGRY has showed a green trend with a performance of 2.00% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 24.52 on recent trading dayincreased the stock’s daily price by 10.73%. The company’s shares are currently down -31.57% year-to-date, but still down -8.18% over the last five days. On the other hand, Surgery Partners Inc (NASDAQ:SGRY) is -25.34% down in the 30-day period. We can see from the shorts that 10.07 million shares have been sold at a short interest cover period of 10.96 day(s).

The consensus price target as assigned by Wall Street analysts is $34.5, which translates to bulls needing to increase their stock price by 36.55% from its current value. Analyst projections state that SGRY is forecast to be at a low of $31 and a high of $40.

Surgery Partners Inc (SGRY) estimates and forecasts

Surgery Partners Inc share prices are performing particularly well not compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -14.02 percent over the past six months and at a -4.00% annual growth rate that is well below the industry average of 7.70%. The year-over-year growth rate is expected to be 12.20%, up from the previous year.

Consensus estimates provided by 11 financial analysts predict the company will bring in an average of 828.08M in revenue for the current quarter. 9 analysts expect Surgery Partners Inc to make 802.02M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 735.4M and 717.4M respectively. Analysts predict that the company’s current quarter sales will jump, forecast at 12.60%. Forecasts for the next quarter put sales growth at 11.80%.

Looking at the company’s year-over-year earnings, the past five years showed a positive earnings growth rate of 54.69%. Surgery Partners Inc earnings are expected to increase by -15.54% in 2024, but the outlook is positive 46.10% per year for the next five years.

SGRY Dividends

Surgery Partners Inc’s next quarterly earnings report is expected to be released in January.

Surgery Partners Inc (NASDAQ:SGRY)’s Major holders

Upon looking at major shareholders, it appears that insiders hold 1.12% of Surgery Partners Inc shares, and 110.10% of them are in the hands of institutional investors. The stock currently has a share float of 111.34%. Surgery Partners Inc stock is held by 269.0 institutions, with BAIN CAPITAL INVESTORS LLC being the largest institutional investor. By 2024-06-30, it held 39.6493% of the shares, which is about 49.95 million shares worth $1.19 billion.

FMR LLC, with 14.1023% or 17.76 million shares worth $422.63 million as of 2024-06-30, holds the second largest percentage of outstanding shares.